SEngine Precision Medicine Announces New Non-Small Cell Lung Cancer Study at Johns…
SEATTLE, Sept. 27, 2022 (GLOBE NEWSWIRE) -- SEngine Precision Medicine Inc., a Seattle-based precision oncology company revolutionizing cancer therapies by pre-testing drugs on…